| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |